PAVmed- Warrants (29/01/2022) Common Stock

The latest common stock for PAVMW is $6K as of June 2026. That compares with $20M in the prior-year period — down 100.0% year over year. Investors often review this figure alongside PAVmed- Warrants (29/01/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PAVMW's common stock moved from $20M to $6K — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PAVmed- Warrants (29/01/2022)'s operating scale or balance-sheet position.

A common stock figure of $6K for PAVMW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PAVMW's common stock ($6K), review year-over-year change from $20M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PAVmed- Warrants (29/01/2022)'s common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.